Diabetes Self-Management Blog

Get tips and insights from health-care professionals and people with diabetes, share your thoughts, and ask questions on our blog.

Sign up for our weekly e-mail newsletter and receive a FREE GIFT! Enter your e-mail below.



 

Learn more
Sample e-newsletter

Learn more about diabetes

Links to help you learn more about diabetes.

Ask a diabetes expert
Other diabetes resources
Browse article topics

 

The Food and Drug Administration (FDA) is advising people who use the long-acting insulin detemir (brand name Levemir) to check their insulin vials to ensure that none are from a potentially dangerous batch that appeared on the U.S. market last week after having been stolen.

At least one of the stolen vials, which number roughly 129,000 in all, surfaced at a medical center in the Houston area. Because these vials did not go through the typical distribution channels, they may not have been stored and handled properly. The FDA has received one report of an adverse reaction resulting from use of one of the stolen vials.

To determine whether the insulin you are using comes from an affected lot, check the lot number on the side of the box of insulin or on the side of the vial. Insulin from lots XZF0036, XZF0037, and XZF0038 should not be used and should be replaced with insulin from another lot of Levemir.

For information about how to handle insulin vials from the stolen lots, contact the Novo Nordisk Customer Care Center at (800) 727-6500. And to learn more about the stolen vials, see the press release from Novo Nordisk.

POST A COMMENT       


Comments
  1. Thank you for such up to date info as the Levimir Insulin info. Have passed the website onto others re checking lot numbers of possibly stolen insulin. This is wonderful service, keep up such alerts. TU

    Posted by murray |
  2. Thanks for the information. I have a niece that uses this insulin so it is great knowing the information. We will check her vials of insulin.

    Posted by JULIE |

Post a Comment

Note: All comments are moderated and there may be a delay in the publication of your comment. Please be on-topic and appropriate. Do not disclose personal information. For more information, please read our Terms and Conditions.


Insulin & Other Injected Drugs
Insulin Effective and Accepted in Newly Diagnosed Type 2s (10/16/09)
Diabetes Drugs: Pramlintide (09/25/09)
Oral Insulin Conditionally Approved by FDA (09/18/09)
Diabetes Drugs: GLP-1 Agonists (11/04/09)

Diane Fennell
Daily Aspirin: Do Risks Outweigh Benefits? (11/20/09)
Cardiovascular Risk Decreased by Intensive Lifestyle Intervention (11/13/09)
Exercise Wards Off Dangerous Form of Fat (11/06/09)
Syringe Recall; New Treatment Recommendations Released (10/30/09)

 

 

Disclaimer of Medical Advice: You understand that the blog posts and comments to such blog posts (whether posted by us, our agents or bloggers, or by users) do not constitute medical advice or recommendation of any kind, and you should not rely on any information contained in such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs. The opinions and other information contained in the blog posts and comments do not reflect the opinions or positions of the Site Proprietor.


New Tools 2009
Find out what new meters, injection devices, drugs, and other diabetes tools and products were approved or came on the market in 2009.

Homemade Holiday Treats
Make sure there’s something nutritious on the buffet table with these recipes for Turkey meatballs with fresh cranberry glaze, Maple spice cookies, and other delicious dishes.

An Aspirin A Day: Still Recommended for Diabetes?
Review the latest research on the health benefits of daily aspirin therapy for people with diabetes.

Complete table of contents
Get a FREE ISSUE
Subscription questions